Growth of Certain Myeloid Leukemic Cells Can be Stimulated by Interleukin-2

References

• Armitage R. J., Lai A. P., Roberts P. J., Cawley J. C. Certain myeloid cells possess receptors for IL‐2. Brit. J. Haematol 1988; 64: 799–804
   Web of Science ®Google Scholar
• Carron J. A., Cawley J. C. IL‐2 and myelopoiesis: IL‐2 induces blast cells proliferation in some cases of acute myeloid leukemia. Brit. J. Haematol 1989; 73: 168–172
   PubMed Web of Science ®Google Scholar
• Cimino G., Sgadari C., Amadori S., Magliocca V., Poti G. P., Cimono G., Mandelli F. High interleukin‐2 levels in acute myeloid leukemia (AML) are associated with FAB M4 and M5 subtypes. Brit. J. Hematol 1989; 73: 431–431
   PubMed Web of Science ®Google Scholar
• Dukovich W., Wano L., Le thi Bich Thuy, Katz P., Cullen B. R., Kehrl J. H., Greene W. C. A second human interleukin‐2 binding protein that may be a component of high‐affinity interleukin‐2 receptor. Nature 1987; 327: 518–519
   PubMed Web of Science ®Google Scholar
• Foa R., Carett P., Fierro M. T., Bonferroni M., Cardona S., Guarini A., Lista P., Pegoraro L., Mandell F., Gavosto F. Interleukin‐2 does not promote the in vitro and in vivo proliferation and growth of human acute leukemia cells of myeloid and lymphoid origin. Brit. J. Haematol 1990; 75: 34–40
   PubMed Web of Science ®Google Scholar
• Herrman F., Cannista S. A., Griffin J. D. T‐cell monocyte interactions in the production of humoral factors regulating human granulopoiesis in vitro. J. Immunol 1986; 136: 2856–2860
   PubMed Web of Science ®Google Scholar
• Hoshino S., Oshimi K., Tsudo M., Mayasaka M., Teramura M., Masuda M., Motoji T., Mizoguchi M. Flow cytometric analysis of expression of interleukin‐2 receptor beta‐chain (p70–75) on various leukemic cells. Blood 1990; 76: 767–774
   PubMed Web of Science ®Google Scholar
• Kaplan M. E., Clerk C. An improved rosetting assay for detection of human T‐lymphocytes. J. Immunol. Meth 1974; 5: 131–135
   PubMed Web of Science ®Google Scholar
• Korsmeyer S. J., Greene W. C., Cossman J., Hsu S. ‐M., Jensen J. P., Neckers L. M., Marshall S. L., Bakhisi A., Depper J. M., Leonard W. J., Jaffe E. S., Waldman T. A. Rearrangement and expression of immunoglobulin genes and expression of Tac antigen on hairy cell leukemia. Proc. Natl. Acad. Sci. USA 1983; 80: 4522–4525
   PubMed Web of Science ®Google Scholar
• Morgan P. A., Ruscetti F. W., Gallo R. C. Selective in vivo growth of T‐lymphocyte from normal human bone marrows. Science 1976; 193: 1003–1008
   PubMed Web of Science ®Google Scholar
• Panayotides P., Lenkei R., Prowit A. Malignant B‐cells have receptors for and respond to interleukin‐2. Med. Onc. Tumor Pharmacother 1986; 3: 255–259
   PubMedGoogle Scholar
• Ralph P., Jeong G., Welte K., Mertelsmann R., Rabin H., Henderson L. E., Souza L. M., Boone T. C., Robb R. J. Stimulation of immunoglobulin secretion in human B lymphocytes as direct effect of high concentration of IL‐2. J. Immunol 1984; 133: 2442–2446
   PubMed Web of Science ®Google Scholar
• Rambaldi A., Young D. C., Herrman F., Cannista S. A., Griffin J. D. Gamma‐interferon induces expression of the IL‐2 receptor gene in human monocytes. Eur. J. Immunol 1987; 17: 153–160
   PubMed Web of Science ®Google Scholar
• Rayner A. A., Grimm E. A., Lotze M. T., Wilson D. J., Rosenberg S. A. Lymphokine‐activated killer (LAIC) cell phenomenon. IV. Lysis of LAK cell clones of fresh human tumour cells from autologous and multiple allogeneic tumours. J. Natio. Cancer Institute 1985; 75: 67–73
   PubMed Web of Science ®Google Scholar
• Robb R. T., Munch A., Smith K. A. T‐cell growth factors: quantification, specificity and biological relevance. J. Exp. Med 1981; 154: 1455–1459
   PubMed Web of Science ®Google Scholar
• Rosolen A., Nakanishi M., Poplack D. G., Cole D., Quinoses R., Reaman G., Trepel J. B., Cotelingam J. D., Sausville E. A., Marti G. E., Jaffe E. S., Neckers L. M., Colamonici O. R. Expression of interleukin‐2 receptor beta‐subunit in hematopoietic malignancies. Blood 1989; 73: 1968–1972
   PubMed Web of Science ®Google Scholar
• Schwarting R., Gerdes J., Stein H. Expression of interleukin 2 receptor on Hodgkin's and Non‐Hodgkin's lymphomas and macrophages. J. Clin. Pathol 1985; 38: 1196–1200
   PubMed Web of Science ®Google Scholar
• Sharon M., Klausner R., Cullen B. R., Chizzonite R., Leonard W. J. Novel interleukin‐2 receptor subunit detected by cross‐linking under high‐affinity conditions. Science 1986; 234: 859–860
   PubMed Web of Science ®Google Scholar
• Siegel J. P., Sharon M., Smith P. L., Leonard W. J. The IL‐2 receptor beta chain (p70): Role in mediating signal for LAK, NK, and proliferative activities. Science 1987; 238: 75–77
   PubMed Web of Science ®Google Scholar
• Teshigawara K., Wang H. ‐M., Kato K., Smith K. A. Interleukin 2 high‐affinity requires two distinct binding protein. J. Exp. Med 1987; 165: 232–238
   Web of Science ®Google Scholar
• Touw I., Loewenberg B. The proliferative response of B cell chronic lymphocytic leukemia to interleukin‐2: Functional characterization of the interleukin 2 membrane receptors. Blood 1987; 69: 1667–1672
   PubMed Web of Science ®Google Scholar
• Trinchierei G., Matsumoto‐Kobayashi M., Clark S. C., Seehra J., London L., Perussia B. Response of resting human peripheral blood natural killer cells t6 interleukin‐2. J. Exp. Med 1984; 164–170
   Web of Science ®Google Scholar
• Tsudo M., Kozak R. W., Goldman C. K., Waldmann T. A. Contribution of a p75 interleukin 2 binding pep‐tide to a high‐affinity interleukin 2 receptor complex. Proc. Natl. Acad. Sci. USA 1987a; 84: 4215–4219
   PubMed Web of Science ®Google Scholar
• Tsudo M., Goldman C. K., Bongiovanni K. F., Chan W. C., Winton E. F., Yagita M., Grimm E. A., Waldman T. A. The p75 peptide is the receptor for interleukin 2 expressed on large granular lymphocytes and is responsible for the interleukin 2 activation of these cells. Proc. Natl. Acad. Sci. USA 1987b; 84: 5394–5397
   PubMed Web of Science ®Google Scholar
• Uchiyama T., Broder S., Waldman T. A. A monoclonal antibody (TAC) reactive with activated and functionally mature T cells. I. Production of anti‐Tac monoclonal antibody and distribution of Tac(+) cell. J. Immunol 1981; 126: 1393–1397; 1401
   PubMed Web of Science ®Google Scholar
• Wang H. ‐M., Smith K. A. The interleukin 2 receptor. Functional consequences of its bimolecular structure. J. Exp. Med 1987; 166: 1055–1060
   PubMed Web of Science ®Google Scholar